SynthesisMedical oncology (Northwood, London, England)2013

FOLFIRI + bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of published trials.

Giordano Domenico Beretta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.